Travere Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TRAVERE, and when can generic versions of TRAVERE drugs launch?
TRAVERE has one approved drug.
There is one US patent protecting TRAVERE drugs.
There are nineteen patent family members on TRAVERE drugs in fourteen countries.
Summary for Travere
| International Patents: | 19 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Travere
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-001 | Feb 17, 2023 | RX | Yes | No | 9,993,461 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-001 | Feb 17, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
